AtriCure Inc. news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

ATRC 19.24
price chart
AtriCure Announces Definitive Agreement to Acquire Estech
WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation (Afib) medical device provider, and Endoscopic Technologies, Inc. d/b/a Estech (�Estech�), today announced that they have entered into a definitive merger ...
Related articles »  
Why AtriCure, Inc. Shares Surged
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »  
AtriCure to Announce Third Quarter 2014 Financial Results
WEST CHESTER, Ohio, Oct. 3, 2014 (GLOBE NEWSWIRE) -- AtriCure, Inc. (Nasdaq:ATRC), a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, will release its financial results for the third quarter of 2014 ...
Related articles »  
AtriCure Announces Upcoming Investor Conference Schedule
WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation and Left Atrial Appendage Management, today announced that it will present at the Stifel Healthcare Conference 2014 ...
Related articles »  
AtriCure selects Mason to build new headquarters
In a search to build a prominent global headquarters office, local medical device maker AtriCure Inc. selected Mason over other sites in Butler and Warren counties, and chose Mason over the homebase its held in West Chester Twp.
Related articles »  
AtriCure Inc. : AtriCure Completes Acquisition of Estech
AtriCure, Inc. , an Atrial Fibrillation medical device provider, announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a Estech.
Related articles »  
AtriCure Could Start Paying Off
By comparison, a referral to a surgeon doesn't help out the EP, so patient control and market creation are going to be issues for AtriCure, even though cure rates are often well above 80% with experienced doctors. There is a lot of scientific support ...
AtriCure Announces the Release of the AtriClip� FLEX
WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and Left Atrial Appendage Management (LAAM), today announced the introduction of the AtriClip� FLEX, a new ...
Related articles »  
AtriCure plans new headquarters in Butler or Warren county
AtriCure Inc., a growing, locally-based medical device manufacturer, has revealed plans to build new headquarter offices at a Butler or Warren county site yet-to-be-determined, said Andy Wade, vice president and chief financial officer.
Mid-Day Changers: AtriCure, Inc. (ATRC), Remark Media, Inc. (MARK ...
AtriCure, Inc. (ATRC) of the Healthcare sector has gained 1.84% from opening mid-day today with a volume of 112,521 shares and volatility of 2.85%.
Related articles »